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Abstract
 
To examine the widely accepted dogmas that corneal grafts lack passenger leukocytes or cells
capable of migrating directly to lymph nodes (LNs), we tracked the migration of corneal graft-
derived transgenic green fluorescent protein (GFP; Ia
 
b
 
) cells into the draining LNs of allogeneic
(Ia
 
d
 
) recipients. GFP
 
 
 
 cells were identified in cervical LNs several hours after transplantation,
and this traffic was significantly enhanced when grafts were placed in inflamed recipient beds.
Draining cells were Ia
 
b
 
 
 
, CD45
 
 
 
, and CD11c
 
 
 
, and examination of ungrafted corneas revealed
numerous similarly CD45
 
 
 
CD11c
 
 
 
CD3
 
 
 
CD8
 
 
 
 
 
 cells that uniformly lacked major histocom-
patibility complex (MHC) class II expression; transmission electron microscopy confirmed the
presence of morphologically similar cells. After transplantation, or placement in culture, these
CD11c
 
 
 
 cells became class II
 
 
 
 in a time-dependent manner and were capable of allostimula-
tory function. However, the stimulatory capacity of these cornea-derived dendritic cells (DCs)
was suppressed compared with splenic controls. These results demonstrate for the first time that
the cornea is endowed with resident DCs that are universally MHC class II
 
 
 
 but that are capa-
ble of expressing class II antigen after surgery and migrating to draining LNs of allografted
hosts. These data refute the tenet that the cornea is immune privileged due to lack of resident
lymphoreticular cells or due to antigenic sequestration from systemic immunity.
Key words: antigen presentation • dendritic cells • lymph node • MHC antigens • 
transplantation
 
Introduction
 
Corneal transplantation is by far the most common form of
solid tissue transplantation with over 40,000 cases per-
formed annually in the United States (1). Uncomplicated
corneal grafts performed in nonvascularized “low risk” host
beds enjoy a survival rate of 
 
 
 
90% under cover of local im-
mune suppression, and represent one of the most successful
forms of transplantation. This high success rate is overshad-
owed by survival rates of well under 50% when grafts are
placed in “high-risk” hosts whose recipient bed is inflamed
and vascularized, a common finding in patients with a his-
tory of ocular inflammation (2).
The general success of allogeneic corneal transplants ob-
served in hosts with uninflamed and nonvascularized graft
beds has been ascribed to the fact that the cornea and ocu-
lar anterior segment are considered immune privileged sites
(3, 4). Features of the ocular anterior segment that have
been implicated in immune privilege include expression of
a number of immunosuppressive factors by the cornea and
iris-ciliary body (3), Fas ligand expression by the cornea
(5), and the fact that the cornea itself is avascular and de-
void of lymphatics (6). In addition, the central uninflamed
cornea has the unique property of not expressing class II
MHC (Ia/HLA DR) antigens (7–10). In contrast, other
solid organ grafts (e.g., heart, kidney, and skin) are signifi-
cantly endowed with MHC class II
 
 
 
 dendritic “passenger
leukocytes” (11–13) capable of migrating to host lymphoid
organs and stimulating T cells directly by presenting donor-
derived peptides in the context of donor MHC class II (12,
14). It has been argued, however, that due to the putative
absence of corneal bone marrow–derived cells that may
serve as APCs (7, 9), allosensitization in corneal transplan-
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tation relies almost exclusively on the indirect pathway
where host APCs migrate into the graft and present pro-
cessed allopeptides in the context of recipient class II anti-
gens (15, 16). The normal lack of MHC class II
 
 
 
 cells in
the cornea has additionally contributed to the dominant
paradigm of corneal alloimmunity asserting that generation
of immunity to graft antigens is almost exclusively directed
at donor minor (and not MHC) antigens through a T cell
response that is self-restricted (17).
There are, nevertheless, several lines of evidence to sug-
gest that donor MHC antigens are relevant in corneal al-
loimmunity, in particular in the high-risk setting where
the degree of inflammation in the graft bed may augment
the immune response generated to ocular antigens (18).
First, it has been shown that under appropriate inflamma-
tory stimulation, corneal cells are capable of overexpres-
sion of class II antigens (10, 19). Second, some degree of
direct priming of host T cells has been documented in
high-risk transplantation (20), suggesting that inflamed
graft beds may afford a more facile access of donor cells to
host lymphoid organs, particularly to the draining LN
which has recently been shown to be the critical site for
induction of corneal alloimmunity (21). However, in spite
of data that implicate the potential role of donor MHC in
directly priming corneal alloimmunity, the mechanisms by
which graft MHC antigens gain access to host lymphoid
organs has remained unclear.
Herein we provide direct support for our hypothesis
that, contrary to current dogma, donor graft cells express-
ing MHC class II antigens migrate from the corneal trans-
plant to draining LNs, and the traffic of these donor cells to
draining LNs is significantly enhanced in inflamed high-risk
host beds compared with low-risk hosts (with avascular re-
cipient beds). Moreover, we demonstrate that these traf-
ficking cells are CD45
 
 
 
CD11c
 
 
 
 cells that are normally
universally MHC class II
 
 
 
 when resident in the uninflamed
cornea but rapidly become MHC class II
 
 
 
 after transplanta-
tion or when placed in culture. Finally, we demonstrate
that in culture corneal CD11c
 
 
 
 cells spontaneously migrate
out of the cornea and progressively acquire MHC class II
expression, but have modest allostimulatory capacity com-
pared with dendritic cells (DCs)
 
*
 
 derived from the spleen.
 
Materials and Methods
 
Mice.
 
8–10-wk-old mice were used for these experiments;
wild-type mice consisted of BALB/c (H-2
 
d
 
) and C57BL/6 (H-
2
 
b
 
) strains obtained from our Institute breeding facility or pur-
chased from The Jackson Laboratory. Transgenic mice expressing
enhanced green fluorescent protein (GFP) on a C57BL/6 back-
ground (strain C57BL/6-TgN[b-act-EGFP]OsbSer H-2
 
b
 
) were
provided by Dr. Masaru Okabe (Osaka University, Osaka, Japan;
reference 22) and bred in our Institute. Each animal was placed
under general anesthesia by intramuscular injections of ketamine
(3–4 mg) and xylazine (0.1 mg) for each surgical procedure. All
 
protocols were approved by the Schepens Eye Research Institute
Animal Care and Use Committee, and all animals were treated
according to the Association for Research in Vision and Oph-
thalmology Statement for the Use of Animals in Ophthalmic and
Vision Research.
 
Induction of Corneal Neovascularization for Creation of High-Risk
Host Beds.
 
Three interrupted sutures (11–0 nylon, Sharpoint;
Vanguard) were placed in the central cornea of one eye of each
recipient BALB/c mouse to induce inflammatory corneal
neovascularization, which is also associated with significant lym-
phangiogenesis, as described previously (18). 2 wk later, when all
corneas developed extensive neovascularization, all sutures were
removed. The neovascularized corneas then served as high-risk
host beds for corneal transplants.
 
Cauterization of the Corneal Surface.
 
Mice were anesthetized
and placed under the operating microscope. Using the tip of a
handheld thermal cautery (Aaron Medical Industries Inc.), six
burns were applied to the central 50% of the cornea as previously
described in order to induce ingress of (donor) APCs into the
central cornea (23). 2 wk later the cauterized corneas were ex-
cised and used as corneal grafts.
 
Corneal Transplantation.
 
Our standard protocol (21) for mu-
rine orthotopic corneal transplantation was used for these studies.
Briefly, the center of the donor cornea (from transgenic GFP or
wild-type C57BL/6 background mice) was marked with a 2-mm
diameter microcurette, and excised with Vannas scissors (Storz
Instruments Co.) and placed into chilled PBS. The recipient graft
bed was prepared by excising a 1.5-mm site in the central cornea.
The donor button was then placed onto either normal avascular
(low-risk; 
 
n
 
 
 
  
 
5 per time point studied) or neovascularized
(high-risk; 
 
n
 
 
 
  
 
5 per time point studied) graft beds of BALB/c
recipients and secured with eight interrupted 11–0 nylon sutures,
followed by application of antibiotic ointment.
 
Transmission Electron Microscopy.
 
Freshly excised healthy
BALB/c corneas were fixed in Karnovsky solution. After three
washes in cacodylate buffer, corneas were postfixed for 1.5 h in
1% osmium tetroxide in the same buffer. Corneas were washed
with H
 
2
 
O, stained in aqueous 2% uranyl acetate, dehydrated, and
embedded in epon. Sections were cut at 60 Å and a Philips 410
TEM was used for electron microscopy.
 
Abs.
 
The immunohistochemical, immunocytochemical,
and FACS
 
®
 
 staining procedures were performed using the fol-
lowing Abs: purified mouse anti–mouse class II MHC (KH74,
anti-Ia
 
b
 
); FITC-conjugated mouse anti–mouse class II MHC
(AF6–120, anti-Ia
 
b
 
); FITC-conjugated mouse anti–mouse class
II MHC (39–10–8, anti-Ia
 
d
 
); purified rat anti–mouse CD45 (30-
F11, pan-leukocyte marker); purified hamster anti–mouse
CD11c (HL3, DC marker); PE-conjugated hamster anti–mouse
CD11c (HL3); polyclonal rabbit anti-GFP; FITC-conjugated
rat anti–mouse CD8
 
 
 
 (53–6.7, lymphoid DC marker); FITC-
conjugated hamster anti–mouse CD3-e (145–2C11, T lympho-
cyte marker); rabbit polyclonal anti-keratin 12 (K-12, corneal
epithelial cell marker); and rat anti–mouse CD16/32 (2.4G2,
Fc
 
 
 
III/II receptor). The secondary antibodies were Cy5-conju-
gated goat anti–mouse F(ab
 
 
 
)
 
2
 
; Cy3-conjugated donkey anti–rat
IgG; Cy5-conjugated goat anti–Armenian hamster IgG; and
R-conjugated donkey anti–rabbit IgG. Isotype controls included
mouse IgG
 
2a
 
, mouse IgG
 
3
 
, rat IgG
 
2b
 
, rat IgG
 
2a
 
-FITC, hamster
IgG, mouse IgG
 
3
 
-FITC, mouse IgG
 
2a
 
-FITC, and hamster IgG-
PE. All primary mAbs (except where noted) and isotype
matched controls were purchased from BD PharMingen, and
second IgG Abs were purchased from Jackson ImmunoResearch
Laboratories. The anti–K-12 and anti-GFP Abs were gifts of Dr.
 
*
 
Abbreviations used in this paper:
 
 DC, dendritic cell; GFP, green fluorescent
protein; MLR, mixed lymphocyte reaction; TEM, transmission electron
microscopy. 
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Zieske and Dr. Young, respectively, both of the Schepens Eye
Research Institute.
 
Immunofluorescence Confocal Microscopy and Immunocytochemis-
try.
 
Normal and grafted corneas (2, 6, 16, 24, 48, and 72 h af-
ter grafting) were excised from BALB/c mice. Full thickness
corneal tissue or 8-
 
 
 
m frozen sections were fixed in acetone for
immunofluorescence staining for CD3, CD8
 
 
 
, CD11c, CD45,
donor (Ia
 
b
 
) and recipient (Ia
 
d
 
)-type class II MHC, and K-12.
Draining cervical LNs were collected at specific times (6, 16, 24,
48, and 72 h) after grafting, frozen in liquid nitrogen, and fixed
by 4% paraformaldehyde. In some experiments, LN sections (8
 
 
 
m) were fixed in acetone instead of paraformaldehyde. To
block nonspecific staining, sections were blocked with anti-FcR
mAb (CD16/CD32) for 30 min before they were immuno-
stained with primary antibodies or isotype-matched control an-
tibodies for 2 h. Thereafter, the sections were incubated with
secondary antibodies for 1 h. All staining procedures were per-
formed at room temperature, and each step was followed by
three thorough washings in PBS for 5 min each. Finally, the
samples were covered with mounting medium (Vector Labora-
tories) and analyzed using a confocal laser scanning microscope
(Leica TCS 4D; Lasertechnik). At least five sections were ana-
lyzed for each tissue specimen derived from each animal. Repre-
sentative data are presented below. To assay for GFP-expressing
cells, full thickness corneal tissue or 8-
 
 
 
m frozen sections of cor-
nea or lymph nodes were observed by confocal microscopy
without immunofluorescence labeling. In addition, anti-GFP Ab
was used for confirmation of GFP expression in the LN. For im-
munocytochemical studies, cytospin
 
 
 
preparations were made
from cultured corneal explants’ nonadherent cells (see below).
The cytospin slides were fixed in chilled acetone for 15 min and
cells were stained with anti-CD11c and CD45, with relevant
isotype controls after FcR blockade. All experiments were con-
ducted three times, independently.
 
Isolation of Nonadherent Migrating Corneal Cells.
 
Corneal but-
tons were excised from BALB/c mice and placed into a 6-well
plate with 10 buttons per well. The corneal buttons were cul-
tured in 2.5 ml of RPMI-1640 with 10% FBS (Hyclone), 10
mM HEPES, 0.1 mM nonessential amino acid, 100 U/ml of
penicillin, 100 
 
 
 
g/ml of streptomycin (Biowhittaker), and 10
 
 
 
5
 
 M
2-mercaptoethanol (Sigma-Aldrich) and incubated at 37
 
 
 
C for 1,
3, or 6 d. The nonadherent cells were isolated from the superna-
tant of the cultures; the collected supernatant was centrifuged
and the cells resuspended in PBS. The cells were washed once in
PBS, and filtered through a 70-
 
 
 
m nylon cell strainer to remove
corneal fragments. These nonadherent cells were assayed for
their allosensitizing capacity and analyzed by flow cytometry as
described below.
 
Mixed Lymphocyte Reaction.
 
The nonadherent corneal cells,
harvested as described above, were used as stimulators (10
 
5
 
/well
in 96-well plate) in the mixed lymphocyte reactions (MLRs). For
stimulator controls, fresh splenocytes were collected from naive
C57BL/6 mice for syngeneic controls and from naive BALB/c
mice for allogeneic controls. The cells were cultured in 5% FBS
RPMI-1640 and incubated at 37
 
 
 
C for 90 min. Nonadherent
splenic cells were discarded and adherent cells were then washed
three times and incubated for 30 min in serum-free RPMI-1640
to promote DC detachment. The detached cells were collected,
washed with 10% FBS, and used as stimulator cells in the MLR.
Responder cells were splenocytes (2 
 
 
 
 10
 
5
 
/well) derived from
naive C57BL/6 mice. The cultures were incubated at 37
 
 
 
C in
10% FBS RPMI-1640 and [
 
3
 
H]thymidine was added to each cul-
ture (1 
 
 
 
Ci/well) after 72 h. After an additional 18 h of incuba-
 
tion, the cells were collected through a multichannel plate har-
vester (Wallac Inc.) and DNA incorporated [
 
3
 
H]thymidine was
counted by scintillation counting and expressed as mean cpm 
 
 
 
SEM of triplicate cultures.
 
Flow Cytometry.
 
The nonadherent cells were blocked by
anti-FcR mAb (CD16/CD32) before cells were labeled with
FITC-conjugated mouse anti-Ia
 
d
 
 and PE-conjugated hamster
anti–mouse CD11c. For isotype controls, the cells were labeled
with FITC-conjugated mouse IgG
 
3
 
 and PE-conjugated hamster
anti-mouse CD11c. Cells were washed and analyzed using an
Epics XL flow cytometer (Beckman Coulter). The analysis was
done by gating on CD11c-positive cells using appropriate isotype
and cell culture controls to adjust color compensation and gating
parameters. The proportion of CD11c
 
 
 
 cells that were also Ia
positive was quantified. Nonadherent cells of parallel spleen cell
cultures were used as controls to evaluate relative MHC class II
expression. The splenic cultures were established with initially
adherent cells from naive BALB/c mice incubated in culture for
90 min, washed, and then 2.5 ml of 10% FBS RPMI-1640 was
added to the cultures. Supernatants were collected and the har-
vested nonadherent cells were treated identically as nonadherent
cells derived from corneal explants. Cultures were incubated for
1, 3, or 6 d.
 
Data Analysis.
 
Student’s 
 
t
 
 test was used to compare the num-
ber of GFP-positive corneal donor cells migrating to the host LN
at different time points, and for comparing [
 
3
 
H]thymidine uptake
in MLR experiments. Chi-square test for trend analysis was per-
formed to evaluate changes in Ia expression by cornea-derived
DCs. 
 
P
 
 value of 
 
 
 
0.05 was considered significant.
 
Results
 
GFP
 
 
 
 Cells Are Detected in Ipsilateral Draining Cervical
LNs after Corneal Transplantation.
 
LNs were harvested at
various time points after corneal transplantation and exam-
ined under confocal microscopy for detection, localization,
and quantification of GFP
 
 
 
 cells. Control slides, in which
primary antibody was omitted or replaced by an irrelevant
antibody of the same isotype, or LNs contralateral from the
side of the surgery, did not show any reactivity. Controls
with anti-GFP Ab were used to confirm the results of
specimens examined for GFP
 
 
 
 cells. In the low-risk unin-
flamed setting, GFP
 
 
 
 cells were clearly evident as early as
24 h after grafting in the ipsilateral cervical LNs (Fig. 1 A).
GFP expression was patchy and localized largely to the
parafollicular areas of the LN with a density of 375 
 
 
 
 66
cells/mm
 
2
 
 at 24 h (Fig. 1 C; group 1). The number of
GFP
 
 
 
 cells increased to 633 
 
 
 
 63 cells/mm
 
2
 
 at 48 h, and
decreased to 275 
 
 
 
 90 cells/mm
 
2
 
 by 72 h after transplanta-
tion. In the case of normal donor tissue grafted into in-
flamed high-risk beds, GFP
 
 
 
 cell traffic to ipsilateral host
LNs reached a mean density of 1,090 
 
 
 
 115 cells/mm
 
2
 
 at
24 h (Fig. 1 B), and remained consistently higher than the
traffic observed in low-risk grafting (Fig. 1 C; group 2).
Draining LNs of cauterized donor corneas (thus manipu-
lated to enrich with donor APCs before grafting) trans-
planted into uninflamed host beds also first showed evi-
dence for GFP
 
 
 
 cells at 24 h after transplantation (403 
 
 
 
66 cells/mm
 
2
 
), with increasing numbers of cells detected at
the later time points studied (Fig. 1 C, group 3). When 
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cauterized donor corneas were grafted into high-risk lym-
phatic-rich beds, GFP
 
 
 
 cells were found as early as 6 h af-
ter transplantation, and peaked at 24 h (1,167 
 
 
 
 76 cells/
mm
 
2
 
; Fig. 1 C, group 4).
 
GFP
 
 
 
 Donor Cells Migrate Centrifugally Out of the Corneal
Graft into the Recipient Bed.
 
Based on the finding of signif-
icant GFP
 
 
 
 cells in the draining cervical LNs after corneal
transplantation, we evaluated corneal specimens at various
time points after surgery to examine whether GFP
 
 
 
 cells
could be seen emigrating out of the grafts. When speci-
mens were examined at 24 h (or later) after transplantation
we observed GFP
 
 
 
 cells migrating centrifugally out into
the wild-type recipient beds (Fig. 2). Confocal microscopy
showed that this phenomenon was present for 360 degrees
around the grafts, and was particularly marked for grafts
placed in inflamed high-risk beds.
 
High-risk Corneal Transplantation Leads to Significantly En-
hanced Traffic of MHC Class II
 
 
 
 Donor Cells to Draining
LNs.
 
To ensure that the GFP detection in the draining
LNs was a reflection of intact donor-derived cells migrating
to LNs, we performed immunostaining for donor-type
MHC class II (anti-Ia
 
b
 
 Ab) and GFP (anti-GFP Ab). Re-
sults clearly demonstrated the presence of significant num-
bers of intact Ia
 
b
 
 
 
 cells in the draining LNs of hosts of both
low-risk (Fig. 3 A) and high-risk (Fig. 3 B) corneal grafts.
Donor Ia
 
b
 
 
 
 cells colocalized strongly with GFP expression
(Fig. 3 C). In contrast, we did not detect colocalization of
graft-derived GFP and host Ia
 
d
 
 
 
 cells at the early time
points studied; instead, the large numbers of host Ia
 
d
 
 
 
 cells
in the LNs were GFP
 
 
 
 (Fig. 3 D) suggesting that mobiliza-
tion of host APCs capable of processing corneal antigen
and migrating to draining LNs had not occurred by the
time of our analyses.
Figure 1. GFP  cells are detected in ipsilateral draining cervical lymph
nodes after corneal transplantation. Host draining cervical LN (LN) were
analyzed at different time points after transplantation of transgenic GFP 
grafts. Draining LNs from low-risk corneal grafts (A) exhibited a low
number of GFP  cells at 24 h after transplantation. In contrast, LNs
draining high-risk grafts (B) exhibited a significantly higher number of
GFP  cells. Original magnification, (A and B) 400 . Mean numbers of
GFP  cells present in ipsilateral LN at 24, 48, and 72 h after transplanta-
tion are depicted in C: (1) normal cornea grafted into nonvascularized
bed; (2) normal cornea grafted into inflamed and vascularized high-risk
bed; (3) cauterized (APC-enriched) cornea grafted into nonvascularized bed;
and (4) cauterized cornea grafted into high-risk bed. Mean   SD (cells/
mm2) from cervical LNs of five mice for each group/time point are com-
pared. * denotes statistically significant (P   0.05) difference compared
with the same time points in group 1.
Figure 2. GFP  donor cells are evident migrating centrifugally out of
the corneal graft into the recipient bed. Confocal microscopic analysis
performed on transgenic GFP  grafts (green fluorescence) placed onto
wild-type hosts (shown as black background) revealed migration of do-
nor-derived GFP  cells into the recipient bed. Dashed line demarcates the
graft-host margin. * depicts GFP  cells. Original magnification, 160 . 
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Donor-derived Cells in the Draining LNs Are Bone Marrow
Derived.
 
The data above demonstrated traffic of donor-
derived cells to host LNs. As many nucleated, including
corneal, cells are capable of expressing MHC class II anti-
gens under the appropriate inflammatory conditions (10,
19), we tested whether the origin of the migrating cells is
corneal (i.e., epithelial) or bone marrow derived. Resident
corneal epithelial cells can be differentiated from bone mar-
row and lymphoreticular cells by their failure to express the
pan-leukocyte marker CD45, and their specific expression
of keratin-12 (24).
Our results showed that whereas corneal cells exhibited
K-12 expression (Fig. 4 A), there was no K-12 expression
in any of the LNs assayed at the time points studied (Fig. 4
B). To establish the bone marrow derivation of the migrat-
ing cells, we performed double staining on the specimens
to colocalize CD45 and donor Ia expression (corneal kera-
tocytes and epithelial cells do not express CD45). Exami-
nation of draining LNs from grafts revealed significant
numbers of CD45
 
 
 
 cells in the LNs, and a subpopulation
of these cells expressing donor Ia
 
b
 
 (Fig. 4 C). Similar data
were derived when double staining was performed for do-
nor-type Ia and CD11c. Most donor cells localized to the
parafollicular areas of the draining LNs. No CD3
 
 
 
 
 
cells
expressing donor Ia were observed at any of the time
points studied.
 
Resident Corneal MHC Class II–negative Bone Marrow–
derived Cells Express MHC Class II after Transplantation-
induced Inflammation.
 
The finding of bone marrow–
derived donor class II
 
 
 
 cells in the draining LN led us to
focus on the origin of these cells in the corneal graft. Trans-
mission electron microscopy (TEM) demonstrated presence
of numerous DCs interdigitating among the corneal epi-
thelial cells (Fig. 5 A). Cells with similar morphology were
also identified in the corneal stroma. Confocal analysis of
the same specimens revealed numerous cells that were
CD45
 
 
 
 and CD11c
 
 
 
 (Fig. 5 B), but uniformly failed to ex-
press class II antigens (Fig. 5 C), demonstrating that central
areas of corneal tissue procured for grafting are indeed uni-
versally and normally MHC class II negative. However,
within 24 h after surgical inflammation these cells became
positive for Ia
 
b
 
 (Fig. 5 D). The coexpression by both grafted
corneas and draining LNs of CD45
 
 
 
CD11c
 
 
 
Ia
 
b
 
 
 
 cells sug-
gested that corneal grafts have an endowment of resident
MHC class II–negative bone marrow–derived cells that
may, under appropriate stimulation, express Ia and traffic to
draining LNs. The donor CD11c
 
 
 
 cells in the cornea were
uniformly CD8
 
 
 
 
 
 and CD3
 
 
 
 in all specimens studied.
 
Cultured Corneal DCs Have Modest Allostimulatory Capaci-
ty.
 
The above experiments, based on in situ confocal
studies, provided evidence for resident corneal MHC class
II
 
 
 
 DCs capable of trafficking to draining LNs as more ma-
Figure 3. High-risk corneal transplantation
is associated with enhanced traffic of MHC
class II  donor cells to draining LNs. Cervical
LNs from BALB/c hosts grafted with C57BL/6
background mice were procured and immu-
nostained for detection of donor (Iab) and host
(Iad) derived MHC class II (green) and GFP
(red) expression. Clusters of Iab  cells were
clearly visible in the draining LNs in low-risk
hosts (A); significantly higher numbers of cells
were detected in the high-risk setting (B).
Graft-derived GFP colocalized with donor-
type Iab (yellow; C); in contrast, GFP (red)
did not colocalize with host class II  (Iad;
green) cells (D). Arrows demarcate the
parafollicular areas of the LNs. Representative
data at 48 h; original magnifications 1,000 
(A and B) and 400  (C and D). 
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ture MHC class II–expressing cells. To further phenotype
and study the function of these cells in vitro, normal
BALB/c-derived corneas were excised and placed in cul-
ture as described in Materials and Methods. Using standard
techniques of harvesting DCs in culture, the nonadherent
floating cells were procured and stained for CD11c dem-
onstrating ample expression of this DC marker (Fig. 6 A);
similar results were obtained for CD45 (data not shown).
These corneal cells, or equal number of splenic CD11c
 
 
 
cells, were then harvested and used as stimulators in MLR
assays with allogeneic responder C57BL/6 splenic cells;
syngeneic C57BL/6-derived corneal or splenic cells served
as syngeneic stimulator controls (Fig. 6 B). Results demon-
strate that 1 d-cultured allogeneic corneal cells have no de-
monstrable allostimulatory capacity; however, modest stim-
ulation of C57BL/6 responders was observed with BALB/c
corneal cells cultured for 3 d (stimulation index, 2.1) or 6 d
(stimulation index, 2.6) but not with syngeneically derived
corneal cells (Fig. 6 B; 
 
P
 
 
 
  
 
0.01). However, the stimula-
tory capacity of these corneal cells was significantly lower
than that observed for allogeneic splenic controls (stimula-
tion index, 13.5; 
 
P
 
 
 
  
 
0.001).
To further phenotype these cells, normal corneas were ex-
cised, placed in culture, and incubated for different periods.
The nonadherent cells were harvested, and subjected to two-
color staining (CD11c-PE and Ia
 
d
 
-FITC) for flow cytometric
analysis. Similarly derived splenic nonadherent cells were used
 
as controls. 84% of splenic CD11
 
 
 
 cells were Ia
 
 
 
 compared
with 39% of corneal CD11C
 
 
 
 cells after 1 d of culture. Pro-
longed culture of the cells led to 47 and 64% Ia-positivity at
days 3 and 6, respectively (Fig. 7; 
 
P
 
 for trend 
 
 
 
0.05), suggest-
ing that the differential capacity of these DCs to stimulate al-
logeneic responders based on culture time is due at least in
part to their relative expression of MHC class II.
 
Discussion
 
The dual requirement for intimate APC–T cell interac-
tion, and a microenvironment which facilitates expansion
of primed T cells, is afforded by lymphoid organs that drain
APCs from the periphery and bring them in close proxim-
ity to naive T cells (13). In solid organ transplantation the
concept that access of donor-derived cells to afferent lym-
phatics and consequently to draining LNs is a critical facet
of alloimmunity was introduced by Barker and Billingham
several decades ago through their skin graft studies (25).
Years later, Lechler and Batchelor showed that the key ob-
servation of Barker and Billingham was related to the mi-
gration of MHC class II
 
 
 
 resident donor interstitial cells to
draining LNs, and defined these “passenger leukocytes” as a
critical component of graft immunogenicity (26).
However, the application of these general concepts of
transplantation immunology to the case of corneal alloim-
munity has been unclear, and met with considerable resis-
Figure 4. Donor-derived cells in the drain-
ing LNs are bone marrow derived. The nor-
mal cornea exhibited strong expression of
keratin 12 (K-12) (A). However, examination
of the draining LNs after corneal transplanta-
tion did not exhibit any sign of K-12  cells at
any time point studied (B). Numerous
CD45  (red) cells were seen in the LNs and
double staining for donor Iab (green) exhib-
ited colocalization (yellow) mostly in the
parafollicular areas (arrows) of the draining
LNs (C). No purely green cell was observed,
confirming that all donor MHC class II  cells
are bone marrow derived (CD45 ). Original
magnifications 400  (A), 160  (B), and
400  (C). 
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tance for several reasons. First, the putative lack of any do-
nor-derived passenger leukocytes has been cited as a critical
facet of corneal alloimmunity (7–9, 15). Second, the lack
under normal (uninflamed) circumstances of any corneal
lymphatics (6) has led to a focus on antigen and APC traffic
via the oculosplenic axis (through the venous circulation)
rather than the more “conventional” route of APC traffic
to draining LNs through lymphatics (27). However, there
is now ample evidence to suggest that draining LNs are a
major reservoir of alloreactive T cells in corneal transplan-
tation (20, 21); in fact we have recently shown that genera-
tion of corneal alloimmunity is critically dependent on a
Figure 5. Resident corneal CD11c  cells
upregulate expression of MHC class II after
surgical inflammation. The center of normal
uninflamed corneas, corresponding to areas
procured for transplantation, contains numer-
ous DCs (arrow heads) interdigitating be-
tween epithelial cells (arrows) as seen by TEM
(A). These cells express CD11c (B), but uni-
formly fail to express MHC class II (Iab) anti-
gens (C). Within 24 h of surgery, these DCs
begin to coexpress Iab (D). Original magnifi-
cations 7,500  (A); 400  (B–D).
Figure 6. CD11c  cells migrating out of cultured corneal explants have modest allostimulatory capacity. Corneal explants were placed in culture, and
the nonadherent cells harvested and stained for CD11c expression; representative data from 3 d-cultured explants shown (A). 105 cells harvested from
BALB/c (allogeneic) or C57BL/6 (syngeneic) corneal explants kept in culture for 1, 3, or 6 d were used as stimulators for 2   105 C57BL/6 splenocytes
in MLRs; splenic cells were used as control stimulators (B). Data demonstrate modest allostimulatory capacity by corneal cells cultured for 3 d or longer. 
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functional ocular-lymphatic axis, and that lymphadenec-
tomy leads to indefinite survival of corneal grafts (21). We
propose, therefore, that at issue is not whether there is ac-
cess of corneal graft antigens to draining LNs, but rather
the source and route of these antigens.
Our data demonstrate that there is ample traffic of donor
MHC class II  cells to draining LNs after corneal transplan-
tation, and this traffic is significantly greater emanating
from high-risk as compared with low-risk grafts. We show
that the origin of these draining cells are resident bone
marrow-derived (CD45 ) dendritic (CD11c ) cells in the
cornea that are normally universally MHC class II  but that
express class II antigen in vivo after surgical inflammation,
or after in vitro culturing. Our data demonstrating migra-
tion of MHC class II  DCs from the graft have similarities
to the experimental work of Roake et al. (14) in which
they depleted Ia  cells from the heart with systemic admin-
istration of LPS and grafted such manipulated hearts into
allogeneic hosts showing localization of donor-derived Ia 
cells in host spleens, thereby demonstrating that phenotypi-
cally normal (Ia ) passenger leukocytes may be derived
from progenitor or immature (Ia ) DCs. However, the dis-
tinctive feature of the cornea, as demonstrated by our data,
is that all of the trafficking donor DCs begin as MHC class
II  cells even without any prior systemic manipulation.
Previous studies that have focused on the distribution of
ocular surface APCs (7–10, 15), including from our group
(23), have made reference to these cells being MHC class
II  in the corneoscleral limbus (the vascularized area adja-
cent to the cornea) where they are recruited from the in-
travascular compartment. It remains unknown whether
the CD11c  cells described in this study represent a pro-
genitor DC population that does not express class II unless
stimulated to do so, or whether their expression of MHC
class II antigen is in fact actively suppressed once they re-
side in the cornea in response to one or more of the im-
munosuppressive factors secreted by this tissue (3). If so,
the concept of corneal “immune privilege” based on the
putative absence of APC populations in the cornea (7)
may well need to be restated as being due rather to the
suppressed expression of class II by the numerous
CD45 CD11c  cells in the cornea.
Similar to our data demonstrating acquisition of MHC
class II by corneal DCs in culture, Larsen et al. have dem-
onstrated that migration of epidermal Langerhans cells
from skin transplants and explants is likewise associated
with upregulation in MHC class II expression which coin-
cides with augmented immunostimulatory capacity of
these cells (28). However, our data differ from those of
Larsen et al. in one important facet; whereas they demon-
strate that prolonged culturing of epidermal LCs leads to a
higher stimulatory capacity than freshly procured epider-
mal LC or splenic cell controls, our data clearly show that
corneal DCs have a suppressed immunostimulatory capac-
ity compared with spleen cells even after prolonged cultur-
ing and acquisition of higher class II expression. This
dampened sensitizing capacity, along with the fact that cor-
neal DCs are normally universally MHC class II , stresses
the fact that in spite of certain similarities between the cor-
nea and the skin, the cornea indeed retains certain unique
immunological features. These differences likely also ex-
plain the dominant role of the indirect pathway in corneal
allosensitization as we have recently confirmed (29). How-
ever, direct sensitization may become operative in the
high-risk corneal transplant setting given both the higher
trafficking of donor DCs to draining LNs and the aug-
mented expression of MHC class II by donor DCs in re-
sponse to inflammation at the graft site. There is some in-
direct evidence for this hypothesis in the literature where it
has been shown that MHC-disparate corneal grafts experi-
mentally manipulated to be enriched with donor-derived
APCs (before transplantation) are rejected at a significantly
accelerated fashion as compared with grafts without such
enrichment, suggesting that donor corneal APCs may be-
come operative as passenger leukocytes (30). In addition,
recent data (unpublished data) from our group based on
the enzyme-linked immunospot (ELISPOT) assay demon-
strate that directly primed alloreactive T cells are in fact
elicited by corneal grafts, as early as 72 h after transplanta-
tion in the absence of any demonstrable indirect response,
emphasizing that the dominant role played by the indirect
pathway of sensitization should not be understood as an
exclusive one. These observations are in accord with our
data demonstrating numerous donor-derived but no host-
derived DCs in draining LNs early after transplantation,
suggesting that mobilization of host APCs takes longer
than trafficking of donor cells to lymphoid organs. Hence
in the aggregate, there is evidence that both the direct and
indirect pathways of sensitization may concur in corneal
Figure 7. Prolonged culturing of corneal CD11c  cells leads to en-
hanced MHC class II (Iad) expression. Phenotypic analysis of cultured
CD11c  corneal DCs by flow cytometry using two-color staining
(CD11c-PE and Iad-FITC) at days 1, 3, and 6 reveals progressive expres-
sion (logarithmic scale) of MHC class II with increasing culture periods.
Shaded area shows isotype control.267 Liu et al.
transplantation, similar to what has been demonstrated in
other organ grafts such as the skin (31), with the relative
contribution of each pathway based on multiple host and
time-dependent factors.
Finally, the long-standing concept of “ocular antigenic
sequestration” which holds that the principal reason behind
the generally dampened immune response to eye-derived
antigens is the segregation of these antigens from systemic
immunity (32) still holds a dominant place in ocular immu-
nology. The data presented herein, however, suggest that
this tenet as it applies to the cornea is at best a relative, and
not an absolute, concept as donor cells and antigens clearly
are capable of having ample access to host lymphoid tissues
and in fact lead to a chimeric state as has been described for
other solid organ grafts (11).
In summary, our data provide evidence for the first time
of resident bone marrow–derived CD11c  cells in the cor-
nea, and demonstrate significant plasticity in these cells’ ca-
pacity to express class II antigen and effect T cell stimula-
tion depending on the microenvironment in which they
reside. Whether other immune privileged organs are simi-
larly endowed with large numbers of MHC class II 
CD11c  cells, and to what extent this phenotype promotes
immunologic quiescence or tolerance, is so far unknown
and deserves further investigation.
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